FDA approves HPV test to screen for cervical cancer

Share this content:
FDA approves HPV test to screen for cervical cancer
FDA approves HPV test to screen for cervical cancer

(HealthDay News) -- -- The U.S. Food and Drug Administration has approved the first human papillomavirus (HPV) DNA test for women aged 25 years and older that can be used to assess the need for a woman to undergo additional diagnostic testing for cervical cancer. In addition, the test can provide information about a patient's future risk for developing cervical cancer.

The cobas HPV Test detects DNA from 14 high-risk HPV types using a sample of cervical cells. The test specifically identifies HPV 16 and 18, while detecting 12 other types of high-risk HPVs at the same time.

Based on results of the cobas HPV Test, women who test positive for HPV 16 or 18 should have a colposcopy, and women testing positive for at least one of the 12 other high-risk HPV types should have a Pap test to determine the need for a colposcopy.

Other information should be used by health care professionals in conjunction with the cobas HPV Test results, including the patient's screening history and risk factors, as well as current professional guidelines.

The Cobas HPV Test's safety and effectiveness were evaluated in a study of more than 40,000 women 25 years and older undergoing routine cervical exams. The women had either a positive Pap test or cervical cells screening positive for HPV or negative test results. All underwent a colposcopy and cervical tissue biopsy. The biopsy results were compared to the Pap and cobas HPV Test results. Results from this study indicated that the cobas HPV Test was safe and effective for use as a primary screening tool for cervical cancer.

The cobas HPV Test is manufactured by Roche Molecular Systems Inc., based in Pleasanton, Calif.

More Information

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs